Twist Bioscience Corporation (Twist) is a leading provider of synthetic biology tools and services. Its business is subject to various risks, including: • Industry competition: Twist operates in a competitive industry with established players. Increased competition may lead to a loss of market share or lower pricing power. • Technology risks: Twist's products are based on advanced technologies, which are subject to rapid changes and uncertainties. Failure to keep up with the latest technological developments can result in the company falling behind competitors or losing market share. • Regulatory risks: Twist's business is subject to government regulations, which can change frequently. Changes in regulations could impact the company's ability to operate or market its products.